MicroRNAs and cancer


MicroRNAs are a type of small non-coding RNA molecule that performs a vital role in post-transcriptional gene regulation. Since miRNAs were first identified in 1993, a number of studies have demonstrated that they act as tumor suppressors or oncogenes in human cancer, including colorectal, lung, brain, breast and liver cancer, and leukemia. Studies have previously revealed that miRNA profiling is important for the diagnosis and prognosis of patients with cancer, while certain miRNAs possess the potential to be used as diagnostic and prognostic biomarkers or therapeutic targets in cancer. Studies review and examines the roles of miRNAs in prognosis, cancer diagnosis and treatment, discusses the probable therapeutic modality of misusing miRNAs



 


    Related Conference of MicroRNAs and cancer

    October 06-07, 2025

    19th International Conference on Obesity Medicine

    London, UK
    October 27-28, 2025

    14th International Conference on Herbal Medicine and Acupuncture

    Amsterdam, Netherlands
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy
    November 21-22, 2025

    5th International Conference on Medical Research and Development

    Amsterdam, Netherlands
    November 25-26, 2025

    21st World Summit on Blockchain Technology

    Amsterdam, Netherlands
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    May 18-19, 2026

    16th Annual Congress on Clinical and Medical Case Reports

    Aix-en-Provence, France
    October 19-20, 2026

    12th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France

    MicroRNAs and cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in